Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Research Antibodies Market 2017 by Product, Technology, Application, & End Users - Global Forecast to 2022 - Research and Markets

Research and Markets
Posted on: 15 Aug 17

The "Research Antibodies Market by Product (Antibodies (Primary, Secondary)(Mouse, Rabbit), Reagents), Technology (Western Blot, Flow Cytometry, Elisa, Immunoflourescence, Immunohistochemistry), Application, & End User - Global Forecast to 2022" report has been added to Research and Markets' offering.

The increasing R&D activities and expenditure in the life science industry, increasing funding for proteomics research & drug discovery, and growing collaboration between industries and academic institutes are the major factors responsible for the growth of the market during the forecast period. However, the quality concerns over research antibodies (with respect to research reproducibility), cost- and time- intensive antibody development processes, and the pricing pressures faced by prominent market players are the major challenges currently at play in the market.

By product, the research antibodies market (including reagents) is segmented into antibodies and reagents. The research antibodies segment is expected to register the highest CAGR during the forecast period owing to their high sensitivity, specificity, and affinity in various research reactions. Also, they are majorly used in proteomic research and drug development for identification, regulatory characterization, and discovery.

On the basis of end user, the research antibodies market is segmented into pharmaceutical & biotechnological companies, academic & research institutes, and contract research organizations. The pharmaceutical & biotechnological companies segment is expected to grow at the highest CAGR during the forecast period. This is primarily due to the increasing research in the fields of genomics and proteomics and the high uptake of research-specific antibodies in the drug discovery and development process.

In 2016, North America commanded a major share of the research antibodies market. However, Asia-Pacific is expected to witness the highest growth during the forecast period. The significant growth of the Asia-Pacific market is mainly attributed to the growing proteomics and genomics research & increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Research Antibodies Market, By Product

7 Research Antibodies Market, By Technology

8 Research Antibodies Market, By Application

9 Research Antibodies Market, By End User

10 Research Antibodies Market, By Region

11 Competitive Landscape

12 Company Profiles

  • Abcam PLC
  • Active Motif (U.S.)
  • Affinity Biologicals Inc. (Canada)
  • Agilent Technologies Inc.
  • Becton Dickinson and Company
  • Bethyl Laboratories Inc. (U.S.)
  • Bio Sb (U.S.)
  • Biolegend Inc.
  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • Danaher Corporation
  • Enzo Life Sciences Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd
  • Genscript
  • Himedia Laboratories (India)
  • Jackson Immunoresearch Inc. (U.S.)
  • Lonza
  • Merck Group
  • Miltenyl Biotec (Germany)
  • Origene Technologies Inc. (U.S.)
  • Perkinelmer Inc.
  • Qiagen N.V. (Netherlands)
  • Rockland Immunochemicals Inc. (U.S.)
  • Sysmex Corporation (Japan)
  • Thermo Fisher Scientific Inc.

For more information about this report visit

View source version on

Business Wire

Last updated on: 15/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.